Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatments for NAFLD: State of Art
Alessandro Mantovani, Andrea Dalbeni
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2350-2350
Open Access | Times Cited: 160

Showing 26-50 of 160 citing articles:

The impact of piperine on the metabolic conditions of patients with NAFLD and early cirrhosis: a randomized double-blind controlled trial
Masoud Nouri‐Vaskeh, Payam Hashemi, Naser Hataminia, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Relevant Aspects of Combined Protocols for Prevention of N(M)AFLD and Other Non‐Communicable Diseases
Luis A. Videla, Rodrigo Valenzuela, Jessica Zúñiga‐Hernández, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 7
Closed Access | Times Cited: 5
Remnant cholesterol, a potential risk factor of metabolic dysfunction-associated fatty liver disease
Xuanyu Hao, Dongyang Li, Xingyong Huang, et al.
Nutrition & Metabolism (2025) Vol. 22, Iss. 1
Open Access
Poria cocos-Derived Exosome-like Nanovesicles Alleviate Metabolic Dysfunction-Associated Fatty Liver Disease by Promoting Mitophagy and Inhibiting NLRP3 Inflammasome Activation
Tao Wang, Jun Zhao, Qiu-Yi Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2253-2253
Open Access
Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk
Siarhei A. Dabravolski, Evgeny E. Bezsonov, Mirza S. Baig, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4459-4459
Open Access | Times Cited: 38
Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk
Anita M. van den Hoek, Jelle C. B. C. de Jong, Nicole Worms, et al.
Metabolism (2021) Vol. 124, pp. 154873-154873
Open Access | Times Cited: 37
Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms
Hager H. Shaaban, Ibrahim AlZaim, Ahmed El‐Mallah, et al.
Life Sciences (2022) Vol. 308, pp. 120956-120956
Closed Access | Times Cited: 26
Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention
Lucrezia Irene Maria Campagnoli, Nicoletta Marchesi, Mariapia Vairetti, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2827-2827
Open Access | Times Cited: 24
From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention
Benedetta Maria Motta, Mario Masarone, Pietro Torre, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5458-5458
Open Access | Times Cited: 15
Vitamin E supplementation in the treatment on nonalcoholic fatty liver disease (NAFLD): Evidence from an umbrella review of meta‐analysis on randomized controlled trials
Ming Yue Wang, Kousalya Prabahar, Mihnea‐Alexandru Găman, et al.
Journal of Digestive Diseases (2023) Vol. 24, Iss. 6-7, pp. 380-389
Closed Access | Times Cited: 14
Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso)
Rodrigo O. Moreira, Cynthia Melissa Valério, Cristiane Alves Villela‐Nogueira, et al.
Archives of Endocrinology and Metabolism (2023) Vol. 67, Iss. 6
Open Access | Times Cited: 13
Epidemiology of NAFLD – Focus on diabetes
Zobair M. Younossi, Linda Henry
Diabetes Research and Clinical Practice (2024) Vol. 210, pp. 111648-111648
Closed Access | Times Cited: 4
Protective Effect of Caffeine and Chlorogenic Acids of Coffee in Liver Disease
Daniela Di Pietrantonio, Valeria Pace Palitti, Angelo Cichelli, et al.
Foods (2024) Vol. 13, Iss. 14, pp. 2280-2280
Open Access | Times Cited: 4
Therapeutic Targets and Approaches to Manage Inflammation of NAFLD
Wenjing Geng, Wanying Liao, Xinyuan Cao, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 393-393
Open Access
The Correlation between NAFLD and T2DM
笑 雷
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 229-237
Closed Access
Induced pluripotent stem cell-derived mesenchymal stem cells for modeling and treating metabolic associated fatty liver disease and metabolic associated steatohepatitis: Challenges and opportunities
Bárbara M. Silva, José Bragança
World Journal of Stem Cells (2025) Vol. 17, Iss. 2
Closed Access
Lean Metabolic Dysfunction-Associated Steatotic Liver Disease
Chirag S. Desai, Sweta Lohani, Anuj Sharma, et al.
Journal of Clinical Gastroenterology (2025)
Closed Access
Comparison of efficacy and safety of pioglitazone and SGLT2 inhibitors in treating Asian patients in MASLD associated with type 2 diabetes: A meta-analysis
Lingyan Liu, Deng Yu, Lijuan Yang, et al.
Journal of Diabetes and its Complications (2025) Vol. 39, Iss. 4, pp. 108998-108998
Closed Access
Non-Alcoholic Fatty Liver Disease and Its Progression: Impact of Metabolic Syndrome and Future Treatment Strategies
Nasir Khan, Amir Khan, Shagufta Naseer, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 3, pp. 146-152
Closed Access
LAdherence to the Dietary Approaches to Stop Hypertension Diet was Associated with the Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Observational Studies
Shokouh Momeni, Fatemeh Hajizadeh‐Sharafabad, Mohammad Reza Pashaei
Nutrition Research (2025)
Closed Access
Targeting Polymeric Nanoparticles to Specific Cell Populations in the Liver
Lauren Harkins, Sílvia Vilarinho, W. Mark Saltzman
Biochemistry (2025)
Closed Access
Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease
Rou Tang, Rui Li, He Li, et al.
ACS Nano (2021) Vol. 15, Iss. 11, pp. 17016-17046
Closed Access | Times Cited: 29
Tianhuang formula reduces the oxidative stress response of NAFLD by regulating the gut microbiome in mice
Duosheng Luo, Ling Yang, Huiting Pang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 20
Cellular Functional, Protective or Damaging Responses Associated with Different Redox Imbalance Intensities: A Comprehensive Review
Andrea del Campo, Rodrigo Valenzuela, Luis A. Videla, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 34, pp. 3927-3939
Closed Access | Times Cited: 19
Association between leptin and NAFLD: a two-sample Mendelian randomization study
Ziwei Guo, Hongbo Du, Yi Guo, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 12

Scroll to top